Oxford Nanopore Technologies Limited
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hard… Read more
Oxford Nanopore Technologies Limited - Asset Resilience Ratio
Oxford Nanopore Technologies Limited (ONTTF) has an Asset Resilience Ratio of 20.50% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2024)
This chart shows how Oxford Nanopore Technologies Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Oxford Nanopore Technologies Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $137.70 Million | 20.5% |
| Total Liquid Assets | $137.70 Million | 20.50% |
Asset Resilience Insights
- Good Liquidity Position: Oxford Nanopore Technologies Limited maintains a healthy 20.50% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Oxford Nanopore Technologies Limited Industry Peers by Asset Resilience Ratio
Compare Oxford Nanopore Technologies Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Oxford Nanopore Technologies Limited (2012–2024)
The table below shows the annual Asset Resilience Ratio data for Oxford Nanopore Technologies Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 18.71% | $138.85 Million | $742.05 Million | +12.34pp |
| 2023-12-31 | 6.37% | $49.51 Million | $777.06 Million | -8.12pp |
| 2022-12-31 | 14.49% | $119.41 Million | $823.89 Million | -1.02pp |
| 2021-12-31 | 15.52% | $130.63 Million | $841.87 Million | -17.59pp |
| 2018-12-31 | 33.11% | $58.00 Million | $175.19 Million | +24.73pp |
| 2017-12-31 | 8.38% | $10.00 Million | $119.31 Million | -29.37pp |
| 2016-12-31 | 37.75% | $60.00 Million | $158.94 Million | -3.67pp |
| 2015-12-31 | 41.42% | $45.06 Million | $108.77 Million | -9.96pp |
| 2014-12-31 | 51.38% | $36.12 Million | $70.30 Million | +3.24pp |
| 2013-12-31 | 48.14% | $33.15 Million | $68.87 Million | +3.77pp |
| 2012-12-31 | 44.37% | $23.05 Million | $51.95 Million | -- |